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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYSomatic cells can be reprogrammed to induced pluripotent stem cells (iPSCs) using oncogenic transcription factors. However, this
method leads to genetic aberrations in iPSCs via unknown mechanisms, which may limit their clinical use. Here, we demonstrate
that the supplementation of growthmedia with antioxidants reduces the genome instability of cells transducedwith the reprogramming
factors. Antioxidant supplementation did not affect transgene expression level or silencing kinetics. Importantly, iPSCs made with
antioxidants had significantly fewer de novo copy number variations, but not fewer coding point mutations, than iPSCs made without
antioxidants. Our results suggest that the quality and safety of human iPSCs might be enhanced by using antioxidants in the growth
media during the generation and maintenance of iPSCs.INTRODUCTION
A safe and efficient method for generating patient-specific
pluripotent cells from easily accessible tissues via expres-
sion of the transcription factors OCT4, SOX2, KLF4, and
c-MYC (collectively referred to as the four factors or 4F)
(Takahashi et al., 2007), or some other combination of
defined factors (Yu et al., 2007), would have important
applications in cell-replacement therapy and disease
modeling. A key concern with reprogramming somatic
cells into induced pluripotent stem cells (iPSCs) is the
increased load of genomic aberrations. We and others
have shown that human iPSCs harbor genomic aberrations
and point coding mutations that are absent in the parental
cells (Gore et al., 2011; Hussein et al., 2011; Ji et al., 2012;
Martins-Taylor et al., 2011; Pasi et al., 2011; Taapken
et al., 2011). These mutations occur despite the exclusion
of c-MYC as the reprogramming factor and the use of non-
integrating methods for transgene delivery (Gore et al.,
2011; Young et al., 2012). The causes of these mutations
remain largely unknown.
Evidence indicates that preferential reprogramming of
mutated cells in the starting somatic cell population
(Gore et al., 2011; Ji et al., 2012) and adaptation to growth
in culture (Hussein et al., 2011; Laurent et al., 2011) may
contribute to the somatic mutations found in iPSCs. How-
ever, a significant proportion of the mutations in iPSCs
cannot be exclusively attributed to preexisting rare muta-44 Stem Cell Reports j Vol. 2 j 44–51 j January 14, 2014 j ª2014 The Authortions in the parental cells or to acquisition of mutations
during the passaging of iPSCs (Ji et al., 2012), suggesting
that the mutation rate might be elevated during reprog-
ramming. This finding is consistent with the oncogenic
potential of at least some of the reprogramming factors,
and with the fact that reprogramming-factor-transduced
mouse cells develop genome instability (Gonza´lez et al.,
2013; Mario´n et al., 2009). It is known that the P53
pathway is activated in cells transduced with reprogram-
ming factors and results in apoptosis, cell-cycle arrest,
and senescence (Banito et al., 2009; Hong et al., 2009;
Kawamura et al., 2009; Krizhanovsky and Lowe, 2009;
Mario´n et al., 2009; Utikal et al., 2009). However, in a pre-
vious study, we found that the TP53 gene was not mutated
in any of the iPSCs that harboredmutations (Ji et al., 2012).
Thus, an important challenge now is to identify the aspects
of reprogramming that cause mutations to optimize re-
programming, in order to minimize genome instability
during the derivation of iPSCs.
The acceleration of growth rate following the induction
of reprogramming factors (Ruiz et al., 2011) is expected to
impose greater metabolic demands for energy and precur-
sors for biosynthesis on the cells. During reprogramming,
mitochondria get progressively smaller and less active (Pri-
gione et al., 2010; Suhr et al., 2010), and metabolism shifts
from oxidative respiration to oxidative glycolysis (Varum
et al., 2011). Such a metabolic shift can lead to a buildup
of electrons in the electron transport chain, increasing theirs
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Antioxidants Reduce CNVs in Human iPSCsleakage into the cytoplasm as reactive oxygen species (ROS)
that will cause oxidative stress if the radical-scavenging sys-
tems in the cell are not sufficiently upregulated. High ROS
levels can result in the modification of individual nucleo-
tide bases (such as the mutagenic 7,8 dihydro-8-oxogua-
nine), single- and double-strand breaks (Vafa et al., 2002),
and telomere attrition (von Zglinicki, 2002). Indeed, re-
programming-factor-transduced fibroblasts have elevated
levels of oxidative DNA damage and ROS (Banito et al.,
2009; Esteban et al., 2010). Oneway to prevent this damage
is to supplement the reprogramming cells with ROS scaven-
gers such as N-acetyl-cysteine (NAC) or vitamin C (Vc).
Here, we show that supplementation ofNACandVc during
reprogramming and early passaging of iPSCs generated
from human fibroblasts results in a significant reduction
in de novo copy number variations (CNVs).RESULTS
Antioxidant Reduces ROS and DNA Damage to
Promote Cell Survival during Reprogramming
For reprogramming, we used primary human fibroblasts
that we had previously subjected to whole-exome
sequencing and confirmed that they had no obvious ge-
netic defects in DNA repair genes (Ji et al., 2012). Further-
more, in another study, we found no evidence of an
increased incidence of de novo genomic aberrations near
viral integration sites (Hussein et al., 2011). Here, we used
retroviruses encoding human OCT4, SOX2, KLF4, and
c-MYC (hereafter referred to as 4F) for reprogramming. To
confirm that reprogramming-factor-transduced human
fibroblasts experience oxidative stress, we measured ROS
levels 6 days postinfection. We found that 4F-transduced
human fibroblasts had significantly higher levels of ROS
(Figure 1A). Supplementation of growth media with NAC
reduced ROS levels in 4F- and c-MYC-, but not OCT4,
SOX2, and KLF4 (hereafter referred to as 3F)-transduced
cells (Figure 1A; Figures S1A and S1B available online). In
agreement with the previously reported role of c-MYC in
increasing ROS levels (Vafa et al., 2002), these results sug-
gested that c-MYC is the major factor underlying elevation
of ROS levels during reprogramming. Oxidative damage
has been reported to induce double-strand breaks (Vafa
et al., 2002), and the phosphorylated histone variant
H2AX (gH2AX) is a widely used marker for monitoring
the levels of DNA double-strand breaks. To assess the
extent of DNA double-strand breaks, we performed immu-
nostaining for gH2AX in reprogramming-factor-infected
fibroblasts. Treatment with NAC resulted in a significant
reduction in the proportion of 4F-infected cells with
gH2AX foci (p = 0.029, Fisher’s exact test; Figure 1B). How-
ever, gH2AX levels in 3F-infected cells were not affected byStemNAC treatment (Figures S1C and S1D). Collectively, our
results suggest that a significant proportion of DNA
double-strand breaks arise due to elevated ROS levels dur-
ing reprogramming of human fibroblasts with 4F.
DNA damage caused by forced expression of 4F has been
shown to trigger the DNA damage response and increase
apoptosis and senescence during reprogramming (Mario´n
et al., 2009; Banito et al., 2009). To determine whether
NAC influences the cell survival during reprogramming,
we performed a flow-cytometry-based assay to measure
apoptosis. We found that NAC treatment during reprog-
ramming promoted the survival of 4F-infected cells
(Figure 1C). Taken together, our results suggest that antiox-
idant treatment reduces ROS levels and genome instability,
leading to the increased survival of cells during reprogram-
ming with 4F.
Antioxidant Does Not Alter Transgene Expression and
Silencing during Reprogramming
We used a common viral titer for all of the reprogramming
experiments in antioxidant-treated and -untreated condi-
tions to avoid genetic variability potentially caused by
different levels of expression of the 4F. However, it is
possible that the increased survival observed during reprog-
ramming in the presence of NAC is not due to reduced ROS
levels, but rather reflects the reduced dosage of transgene
expression. To examine whether antioxidants alter the
viral transduction efficiency and transgene expression
level, we used the GFP retrovirus to infect the cells and
treated them with or without NAC. GFP viral infection
reached almost 100% transduction efficiency as revealed
by flow-cytometry analysis. NAC treatment did not signif-
icantly alter the proportion of GFP+ cells or the expression
level of GFP (Figures S2A–S2C), demonstrating that NAC
treatment does not affect viral transduction efficiency
and transgene expression. We conclude that the reduction
in genome instability and apoptosis that occurs during re-
programming is unlikely to be due to reduced transgene
load in NAC-treated cells.
Another possible explanation for the reduction in geno-
toxicity and apoptosis observed during reprogramming in
the presence of NAC may be the shorter duration of trans-
gene expression. To test whether antioxidant treatment
affects the kinetics of exogenous 4F silencing, we per-
formed quantitative PCR (qPCR) analysis at different
time points of reprogramming (Figure 2). We found that
the exogenous expression levels of 4F declined with the
progression of reprogramming in both control and NAC-
treated conditions (Figures 2A–2D), indicative of transgene
silencing. The transgene expression levels of the 4F did not
differ significantly between the untreated and NAC-
treated cells at all tested time points after viral infection
(Figures 2A–2D). Taken together, these results suggestCell Reports j Vol. 2 j 44–51 j January 14, 2014 j ª2014 The Authors 45
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Figure 1. Antioxidant Reduces ROS and
DNA Damage to Promote Cell Survival
during Reprogramming
(A) Flow-cytometry analysis of ROS levels
during reprogramming. Cells at day 6 of
infection with 4F were analyzed and the
mean ± SEM is represented (n = 3 inde-
pendent experiments, Student’s t test,
p = 0.01 for the difference between fibro-
blasts (Fib) and Fib+4F, and p = 0.035
for the difference between Fib+4F and
Fib+4F+Nac).
(B) Immunostaining of gH2AX during re-
programming. Cells at day 5 of infection
with 4F were stained and 100 cells of each
condition were counted for gH2AX-positive
foci. Mean ± SEM is represented (n = 3 in-
dependent experiments, Student’s t test);
scale bar: 5 mm.
(C) Flow-cytometry analysis of cell death
during reprogramming. Cells at day 7 of re-
programming were analyzed and the mean ±
SEM is represented (n = 3 independent ex-
periments, Student’s t test).
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Antioxidants Reduce CNVs in Human iPSCsthat antioxidant treatment does not influence transduc-
tion efficiency, transgene expression, and silencing during
reprogramming, and thus this variable is unlikely to un-
derlie the observed reduction in stress and increased cell
survival during reprogramming.
Antioxidants Reduce Genomic Aberrations in iPSCs
To determine whether mitigation of oxidative stress via
antioxidant supplementation during reprogramming leads
to the generation of iPSCs with better genome integrity, we
generated iPSCs with and without antioxidant supplemen-
tation during reprogramming using the same viral titer and
a common batch of parental cells. Growth-media supple-
mentation with NAC did not significantly change the46 Stem Cell Reports j Vol. 2 j 44–51 j January 14, 2014 j ª2014 The Authorreprogramming efficiency (Figures 3A and 3B). Character-
ization of iPSCs generated with or without antioxidant
treatment showed that they expressed the pluripotency
markers TRA-1-60, SSEA4, and NANOG, and were able to
differentiate into lineages representative of three germ
layers (Figure 3C), suggesting that they are bona fide iPSCs.
The iPSCs made with antioxidant treatment were passaged
in the presence of antioxidants until CNVs were assessed.
Antioxidant treatment during the passaging of iPSCs did
not influence their proliferation or survival (Figures S2D–
S2G). Furthermore, we confirmed that iPSCs made with
or without antioxidants did not have significant differ-
ences in the number of transgene integrations (Figures
S3A and S3B).s
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Figure 2. Antioxidant Does Not Change
Transgene Expression and Silencing dur-
ing Reprogramming
(A–D) qPCR analysis of exogenous OCT4 (A),
SOX2 (B), KLF4 (C), and c-MYC (D) expression
at days 7, 10, and 17 of reprogramming with
or without NAC treatment. Mean ± SEM is
represented (n = 3 independent experi-
ments, Student’s t test). An iPSC line
generated with 4F without NAC treatment
was used to assess transgene silencing after
reprogramming.
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Antioxidants Reduce CNVs in Human iPSCsWe assessed the levels of point mutations in iPSCs pre-
pared with or without antioxidant supplementation via
high-throughput, whole-exome sequencing (Gore et al.,
2011; Ji et al., 2012). DNA from parental fibroblasts, con-
trol iPSCs, and iPSCs made with NAC or Vc supplementa-
tion was subjected to exome capture using the TruSeq
exome capture kit, which targets 62 Mb of coding and
conserved noncoding regions of the human genome,
and the enriched DNA was sequenced on the Illumina
HiSeq platform. We aligned the sequence data to the
human reference (hg19) and identified single-nucleotide
variants (Table 1). Mutations in iPSCs were defined as
variants that are not found in the Database of Single
Nucleotide Polymorphisms (dbSNP v129) and parental
fibroblasts in the genomic regions (33.9 Mb) that had at
least 8-fold sequencing coverage in the data for each
exome. The numbers of coding point mutations in un-
treated iPSCs and iPSCs made with NAC or Vc were highly
variable and consequently we were unable to detect differ-
ences with the number of samples that were sequenced
(Table 1).
We then examined CNVs of iPSCs using the Affymetrix
SNP 6.0 copy number platform. Only arrays that met strin-
gent quality-control criteria (Figure S4A)were retained, and
Genotype Console (v 4.0) was used to identify CNVs as pre-
viously described (Hussein et al., 2011), requiring a mini-
mum of ten consecutive concordant probes with at least
10 kb in length. The number of parental CNVs in eachStemline was similar (Figure 3D), suggesting that the data from
each sample have similar false-negative rates. We discarded
CNVs that overlapped with CNVs in the parental fibro-
blasts or those that are documented in the Database of
Genome Variation (http://projects.tcag.ca/variation/)
because these might represent common polymorphisms
that may preexist in the parental fibroblasts. The median
number of novel CNVs in iPSCs (passage 6) treatedwith an-
tioxidants (NAC and Vc) was significantly lower than
the number of CNVs in the untreated iPSCs (passage 6;
median number of de novo CNVs in untreated iPSCs =
47, median number of de novo CNVs in antioxidant-
treated iPSCs = 12; p < 0.02, Mann-Whitney U test; Fig-
ure 3E). The length distribution of the novel CNVs was
similar among different lines (Figure S4B). We also used
an alternative CNV calling method called PennCNV
(Wang et al., 2007) to verify the results. As before, the anti-
oxidant-treated iPSCs had fewer CNVs than the control
iPSCs (Figure S4C). Taken together, our results suggest
that antioxidant treatment during the generation and
maintenance of iPSCs reduces their genomic aberrations.DISCUSSION
One way to obtain good-quality iPSCs is to screen many
iPSCs lines derived from the same patient tissue for
genomic aberrations. However, given the high number ofCell Reports j Vol. 2 j 44–51 j January 14, 2014 j ª2014 The Authors 47
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Figure 3. Antioxidants Reduce Genomic Aberrations in iPSCs
(A and B) Reprogramming efficiency with or without NAC. Cells were stained with alkaline phosphatase (AP) at day 27 of reprogramming
with 4F. The number of AP+ colonies per 100,000 cells was quantified. Mean ± SEM was represented (n = 4 independent experiments,
Student’s t test).
(legend continued on next page)
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Table 1. Coding Variants Identified in iPSCs via Exome
Sequencing
Sample Name
Number of
Variants
% Known
(dbSNP)
Nonparental
Variants
Exonic
Nonparental
Variants
Fibroblasts 14,590 91 NA NA
CTRL-1 14,754 91 54 19
CTRL-2 14,843 91 49 15
CTRL-3 14,697 91 48 15
CTRL-4 14,920 90 53 17
CTRL-5 14,724 91 40 14
NAC-1 14,752 91 36 11
NAC-2 14,954 90 57 11
NAC-3 14,725 91 43 16
NAC-4 14,814 90 53 18
NAC-5 14,714 91 41 14
VC-1 14,800 91 49 19
VC-2 14,656 91 49 16
VC-3 14,472 90 60 11
VC-4 14,894 90 63 21
The variants shown are in the genomic regions targeted by Truseq exome
capture (including noncoding targeted regions) in all of the iPSCs and fibro-
blasts with a minimum of 8-fold coverage (33.9 Mb for total, 18.5 Mb for
exonic). dbSNP (v.129) is the database of known SNPs.
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Antioxidants Reduce CNVs in Human iPSCscell divisions, compounded by the increased rate of geno-
toxicity during reprogramming (Banito et al., 2009; Gonza´-
lez et al., 2013; Mario´n et al., 2009; Figure 1B), it is likely
that very few iPSCs can be generated without de novo
mutations using current protocols. Thus, the identification
of mutation-free iPSCs would require genome-wide
screening of many colonies, which is labor intensive and
costly. Given the challenges in determining the functional
consequences of genomic aberrations in genes not obvi-
ously implicated in cancer or other diseases, it would be
more desirable to identify the aspects of reprogramming
that cause mutations, and use this knowledge to optimize(C) Characterization of iPSCs. iPSCs of different conditions were stain
smooth muscle actin (alpha-SMA) before or after differentiation, resp
(D) CNV analysis of iPSCs. CNV profiling was performed using Affymet
Genotype Console (v 4.0). The numbers of parental CNVs present in con
from each other (Mann-Whitney U test, p > 0.05).
(E) CNV analysis of iPSCs. Data were analyzed as in (D) except that t
Database of Genomic Variants) CNVs present are displayed. The numb
than in NAC (n = 3) and Vc (n = 4) combined (Mann-Whitney U test,
Stemreprogramming methods to preserve genetic integrity dur-
ing the derivation and maintenance of iPSCs.
Using two independent platforms and different algo-
rithms to process CNV data, we observed that antioxidant
supplementation significantly reduced CNVs in iPSCs. By
directly modulating the levels of CNVs in iPSCs with anti-
oxidant supplementation, we were able to demonstrate
that a significant proportion of genomic aberrations in
iPSCs are incurred after delivery of the reprogramming fac-
tors. If all the mutations in iPSCs were due to preexisting
parental mutations, then the CNVs in iPSCs derived from
a common batch of parental cells with and without antiox-
idant supplementation during reprogramming would not
be different. Theoretically, it is possible that the reprogram-
ming-associated CNVs arise after picking the iPSC colonies
and during early passaging rather than during the reprog-
ramming phase. However, our results do not support this
view. Differential genome instability would be expected
to correlate with increased apoptosis, but we failed to
observe such a difference (Figure S2G).
Vc was shown to improve the quality of mouse iPSCs
based on the tetraploid complementation assay, and this
improvement was attributed to the reduction in DNA
methylation aberrations during reprogramming (Stadtfeld
et al., 2012). As Vc is already present in the standard media
used for the derivation of iPSCs, it was suggested that
further Vc supplementation may not reduce mutations in
iPSCs (Esteban and Pei, 2012). However, our findings indi-
cate that the amount of Vc that is present in commonly
used reprogramming media, such as knockout serum
replacement, may be insufficient to protect 4F-driven re-
programming cells from the elevated oxidative stress that
is incurred during iPS derivation. Our results also suggest
that the improvements observed in tetraploid complemen-
tation upon Vc supplementation (Stadtfeld et al., 2012)
might also be due to a reduction of genomic aberrations
acquired during the derivation of iPSCs.
Our study suggests that a proportion of the somatic
CNVs observed in iPSCs are due to elevated oxidative stress;
however, oxidative stress does not appear to underlie the
point mutations observed in iPSCs (Table 1). The reason
for the specificity of antioxidants for CNVs is unclear, but
it might reflect the fact that the repair of DNA double-
strand breaks is more error prone than the repair ofed with NANOG, SSEA4, and TRA-160, or SOX17, A2B5, and alpha-
ectively. Scale bar: 5 mm.
rix SNP 6.0 and copy number regions were called using Affymetrix
trol (n = 5), NAC (n = 3), or Vc (n = 4) are not significantly different
he numbers of nonparental and novel (i.e., not documented in the
ers of nonparental CNVs are significantly greater in control (n = 5)
p < 0.02).
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Antioxidants Reduce CNVs in Human iPSCsoxidative DNA lesions. Previous studies have reported that
Vc increases the efficiency of reprogramming human cells
in media devoid of antioxidants (Esteban et al., 2010),
and Vc seems to increase reprogramming efficiency by
acting as a cofactor for the JHDM1a/b histone demethy-
lase (Wang et al., 2011). The reduced number of CNVs we
observed in iPSCs generated in standard reprogramming
conditions with Vc supplementation is unlikely due to
Vc’s nonantioxidant function, since NAC, which is
thought to function exclusively as an antioxidant, leads
to a similar reduction in CNVs in iPSCs (Esteban et al.,
2010).
In conclusion, mitigation of oxidative stress during re-
programming and early passaging by antioxidant supple-
mentation protects the genome of reprogramming cells
from DNA damage and results in iPSCs with fewer overall
genomic aberrations. Although the mutation load is
reduced, it remains to be determined whether the use of
antioxidants during reprogramming endows iPSCs with
an improved differentiation potential and/or a reduced
risk of tumorigenicity.EXPERIMENTAL PROCEDURES
Cell Culture
Human neonatal foreskin fibroblasts (ATCC) were cultured in
growthmedium consisting of Dulbecco’smodified Eagle’smedium
(Invitrogen) supplemented with 10% fetal calf serum (Hyclone
Laboratories) and 1 mM L-glutamine (Invitrogen). See the Supple-
mental Experimental Procedures for additional details.
Generation of iPSCs
iPSCs were generated as previously described (Ji et al., 2012). See
the Supplemental Experimental Procedures for additional details.
Measurement of ROS
The ROS level of each sample was measured using 20,70-dichlorodi-
hydrofluorescein diacetate (Invitrogen) according to the manufac-
turer’s instructionswith somemodifications. See the Supplemental
Experimental Procedures for additional details.
Immunocytochemistry
Cells were fixed with PBS containing 4% paraformaldehyde for
20 min at room temperature and washed with PBS. See the Supple-
mental Experimental Procedures for additional details.
Alkaline Phosphatase Staining
Stainingwas performedwith an alkaline phosphatase detection kit
(Millipore) according to the manufacturer’s manual. See the Sup-
plemental Experimental Procedures for additional details.
Preparation of Illumina Sequencing Libraries
Genomic DNA was extracted from iPSCs using the ZYMO
DNA extraction kit, and 1 mg of DNA was used to create Truseq50 Stem Cell Reports j Vol. 2 j 44–51 j January 14, 2014 j ª2014 The Authorpaired-end libraries according to the manufacturer’s protocol.
See the Supplemental Experimental Procedures for additional
details.Affymetrix SNP 6.0 CNV Profiling
CNVs were measured using Affy SNP 6.0 arrays at the Center for
Genomic Analysis facility at Sickkids Hospital (Toronto, Canada).
See the Supplemental Experimental Procedures for additional
details.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and four figures and can be found with this article
online at http://dx.doi.org/10.1016/j.stemcr.2013.11.004.
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